Drug Companies to Pay for Overcharging
A federal district court judge in Boston, MA found three drug makers liable last week for overcharging Medicare, pension funds, insurers, and patients for certain drugs. In a nationwide class action lawsuit, plaintiffs alleged that AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, and Schering-Plough sold drugs to doctors at discounted prices while encouraging them to claim full reimbursement from insurers. The judge dismissed claims against Johnson & Johnson. A calculation of damages to be paid by the defendants is expected by August.
Source: "AstraZeneca, Bristol Overcharged on Drugs, Judge Says" by Cary O’Reilly, published at Bloomberg.com.



